Improving active surveillance for men with low-risk prostate cancer
Planning to implement high-quality active surveillance in new-onset favorable risk prostate cancer
['FUNDING_OTHER'] · UNIVERSITY OF MISSOURI-COLUMBIA · NIH-10869475
This study is looking to help men with low-risk prostate cancer by making sure they get the right kind of monitoring, so they can avoid unnecessary treatments and side effects, and it involves working with urologists in Michigan to improve care for these patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MISSOURI-COLUMBIA (nih funded) |
| Locations | 1 site (COLUMBIA, UNITED STATES) |
| Trial ID | NIH-10869475 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the implementation of active surveillance for men diagnosed with favorable-risk prostate cancer, which is a less aggressive form of the disease. The study aims to identify patients with indolent tumors and ensure they are monitored effectively to prevent unnecessary treatment and its associated side effects. By utilizing confirmatory testing methods like prostate biopsy or MRI within six months of diagnosis, the research seeks to improve the accuracy of patient selection for surveillance. The project is being conducted in collaboration with a large network of urologists in Michigan, aiming to standardize and improve the quality of care for these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with favorable-risk prostate cancer who are considering active surveillance as a treatment option.
Not a fit: Patients with aggressive forms of prostate cancer or those requiring immediate intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of low-risk prostate cancer, reducing unnecessary treatments and improving patient quality of life.
How similar studies have performed: Previous research has shown that improving monitoring and adherence to active surveillance protocols can enhance patient outcomes, indicating that this approach has potential for success.
Where this research is happening
COLUMBIA, UNITED STATES
- UNIVERSITY OF MISSOURI-COLUMBIA — COLUMBIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SALES, ANNE EVELYN — UNIVERSITY OF MISSOURI-COLUMBIA
- Study coordinator: SALES, ANNE EVELYN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, Chronic Disease, Disease